IDSA Disclaimer As of the time of this publication, updates have been made to IDSA's
Guidelines on the Diagnosis of COVID-19. For the most updated version of these guidelines …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has brought
a new wave of challenges to health care, particularly in the area of rapid diagnostic test …

The diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
globally has relied extensively on molecular testing, contributing vitally to case identification …

This document provides interim guidance to laboratories and other stakeholders involved in
diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It covers …

Background Management and control of coronavirus disease 2019 (COVID-19) relies on
reliable diagnostic testing. Objectives To evaluate the diagnostic test accuracy (DTA) of …

Objectives To illustrate how patient risk and clinical costs are driven by false-positive and
false-negative results. Methods Molecular, antigen, and antibody testing are the mainstay to …

Molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
gold standard for diagnosis of coronavirus disease 2019 (COVID-19), but the clinical …

The ongoing coronavirus disease (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) poses a severe threat to human health and the …

ABSTRACT The coronavirus disease (COVID-19) pandemic has placed the clinical
laboratory and testing for SARS-CoV-2 front and center in the worldwide discussion of how …

ABSTRACT Introduction: A novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) was reported via nucleic acid identification in December, 2019. Accuracy of SARS …